Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06241807 ×

NCT06241807

This funder is selected. Its supporting articles are shown below.

NCT062418071

Articles mentioning NCT06241807

1 articles · page 1 of 1

Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA–IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study

jitc · abstract · 2026-06-19 · 1 matching annotations

78.2%

NCT06241807 camrelizumab NSCLC chemotherapy

…juvant camrelizumab plus chemotherapy.Trial registration number NCT06241807.…